Clear Harbor Asset Management LLC Buys 168 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Clear Harbor Asset Management LLC boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,290 shares of the medical equipment provider’s stock after acquiring an additional 168 shares during the quarter. Clear Harbor Asset Management LLC’s holdings in Intuitive Surgical were worth $4,849,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the company. Mirador Capital Partners LP grew its holdings in shares of Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after purchasing an additional 50 shares during the last quarter. M.E. Allison & CO. Inc. purchased a new position in shares of Intuitive Surgical in the fourth quarter worth about $449,000. Seilern Investment Management Ltd bought a new position in Intuitive Surgical during the 4th quarter worth approximately $82,517,000. Exome Asset Management LLC lifted its position in Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares during the last quarter. Finally, Consolidated Planning Corp boosted its stake in shares of Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after purchasing an additional 1,198 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares in the company, valued at $12,391,166.97. The trade was a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 43,509 shares of company stock valued at $22,602,212. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Trading Up 1.5 %

Intuitive Surgical stock opened at $592.64 on Tuesday. Intuitive Surgical, Inc. has a 12 month low of $362.14 and a 12 month high of $597.68. The firm has a market cap of $211.09 billion, a price-to-earnings ratio of 95.28, a PEG ratio of 5.04 and a beta of 1.39. The stock has a fifty day simple moving average of $540.66 and a two-hundred day simple moving average of $499.64.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the stock. Citigroup upped their price objective on shares of Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Piper Sandler reiterated an “overweight” rating and issued a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. JPMorgan Chase & Co. upped their target price on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Raymond James lifted their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Monday, October 14th. Finally, Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.